These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 36097776)
21. Accuracy of IOTA Simple Rules, IOTA ADNEX Model, RMI, and Subjective Assessment for Preoperative Adnexal Mass Evaluation: The Experience of a Tertiary Care Referral Hospital. Vilendecic Z; Radojevic M; Stefanovic K; Dotlic J; Likic Ladjevic I; Dugalic S; Stefanovic A Gynecol Obstet Invest; 2023; 88(2):116-122. PubMed ID: 36716716 [TBL] [Abstract][Full Text] [Related]
22. Multicentre external validation of IOTA prediction models and RMI by operators with varied training. Sayasneh A; Wynants L; Preisler J; Kaijser J; Johnson S; Stalder C; Husicka R; Abdallah Y; Raslan F; Drought A; Smith AA; Ghaem-Maghami S; Epstein E; Van Calster B; Timmerman D; Bourne T Br J Cancer; 2013 Jun; 108(12):2448-54. PubMed ID: 23674083 [TBL] [Abstract][Full Text] [Related]
23. A prospective validation of the IOTA logistic regression models (LR1 and LR2) in comparison to subjective pattern recognition for the diagnosis of ovarian cancer. Nunes N; Ambler G; Hoo WL; Naftalin J; Foo X; Widschwendter M; Jurkovic D Int J Gynecol Cancer; 2013 Nov; 23(9):1583-9. PubMed ID: 24088790 [TBL] [Abstract][Full Text] [Related]
24. Subjective assessment versus ultrasound models to diagnose ovarian cancer: A systematic review and meta-analysis. Meys EM; Kaijser J; Kruitwagen RF; Slangen BF; Van Calster B; Aertgeerts B; Verbakel JY; Timmerman D; Van Gorp T Eur J Cancer; 2016 May; 58():17-29. PubMed ID: 26922169 [TBL] [Abstract][Full Text] [Related]
25. Improving strategies for diagnosing ovarian cancer: a summary of the International Ovarian Tumor Analysis (IOTA) studies. Kaijser J; Bourne T; Valentin L; Sayasneh A; Van Holsbeke C; Vergote I; Testa AC; Franchi D; Van Calster B; Timmerman D Ultrasound Obstet Gynecol; 2013 Jan; 41(1):9-20. PubMed ID: 23065859 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of IOTA simple rules, O-RADS, and CA125 to distinguish benign and malignant adnexal masses. Xie WT; Wang YQ; Xiang ZS; Du ZS; Huang SX; Chen YJ; Tang LN J Ovarian Res; 2022 Jan; 15(1):15. PubMed ID: 35067220 [TBL] [Abstract][Full Text] [Related]
28. The use of sonographic subjective tumor assessment, IOTA logistic regression model 1, IOTA Simple Rules and GI-RADS system in the preoperative prediction of malignancy in women with adnexal masses. Koneczny J; Czekierdowski A; Florczak M; Poziemski P; Stachowicz N; Borowski D Ginekol Pol; 2017; 88(12):647-653. PubMed ID: 29303221 [TBL] [Abstract][Full Text] [Related]
29. Strategies to diagnose ovarian cancer: new evidence from phase 3 of the multicentre international IOTA study. Testa A; Kaijser J; Wynants L; Fischerova D; Van Holsbeke C; Franchi D; Savelli L; Epstein E; Czekierdowski A; Guerriero S; Fruscio R; Leone FP; Vergote I; Bourne T; Valentin L; Van Calster B; Timmerman D Br J Cancer; 2014 Aug; 111(4):680-8. PubMed ID: 24937676 [TBL] [Abstract][Full Text] [Related]
30. Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group. Timmerman D; Ameye L; Fischerova D; Epstein E; Melis GB; Guerriero S; Van Holsbeke C; Savelli L; Fruscio R; Lissoni AA; Testa AC; Veldman J; Vergote I; Van Huffel S; Bourne T; Valentin L BMJ; 2010 Dec; 341():c6839. PubMed ID: 21156740 [TBL] [Abstract][Full Text] [Related]
31. Performance of the IOTA ADNEX model in preoperative discrimination of adnexal masses in a gynecological oncology center. Araujo KG; Jales RM; Pereira PN; Yoshida A; de Angelo Andrade L; Sarian LO; Derchain S Ultrasound Obstet Gynecol; 2017 Jun; 49(6):778-783. PubMed ID: 27194129 [TBL] [Abstract][Full Text] [Related]
32. External validation of IOTA simple descriptors and simple rules for classifying adnexal masses. Alcázar JL; Pascual MA; Graupera B; Aubá M; Errasti T; Olartecoechea B; Ruiz-Zambrana A; Hereter L; Ajossa S; Guerriero S Ultrasound Obstet Gynecol; 2016 Sep; 48(3):397-402. PubMed ID: 26748432 [TBL] [Abstract][Full Text] [Related]
33. External Validation of the Ovarian-Adnexal Reporting and Data System (O-RADS) Lexicon and the International Ovarian Tumor Analysis 2-Step Strategy to Stratify Ovarian Tumors Into O-RADS Risk Groups. Timmerman S; Valentin L; Ceusters J; Testa AC; Landolfo C; Sladkevicius P; Van Holsbeke C; Domali E; Fruscio R; Epstein E; Franchi D; Kudla MJ; Chiappa V; Alcazar JL; Leone FPG; Buonomo F; Coccia ME; Guerriero S; Deo N; Jokubkiene L; Kaijser J; Scambia G; Andreotti R; Timmerman D; Bourne T; Van Calster B; Froyman W JAMA Oncol; 2023 Feb; 9(2):225-233. PubMed ID: 36520422 [TBL] [Abstract][Full Text] [Related]
34. External validation of diagnostic models to estimate the risk of malignancy in adnexal masses. Van Holsbeke C; Van Calster B; Bourne T; Ajossa S; Testa AC; Guerriero S; Fruscio R; Lissoni AA; Czekierdowski A; Savelli L; Van Huffel S; Valentin L; Timmerman D Clin Cancer Res; 2012 Feb; 18(3):815-25. PubMed ID: 22114135 [TBL] [Abstract][Full Text] [Related]
35. Diagnostic performance of IOTA simple rules for adnexal masses classification: a comparison between two centers with different ovarian cancer prevalence. Ruiz de Gauna B; Rodriguez D; Olartecoechea B; Aubá M; Jurado M; Gómez Roig MD; Alcázar JL Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():10-4. PubMed ID: 26066289 [TBL] [Abstract][Full Text] [Related]
36. Two-Step Strategy for Optimizing the Preoperative Classification of Adnexal Masses in a University Hospital, Using International Ovarian Tumor Analysis Models: Simple Rules and Assessment of Different NEoplasias in the adneXa Model. Esquivel Villabona AL; Rodríguez JN; Ayala N; Buriticá C; Gómez AC; Velandia AM; Rodríguez N; Alcázar JL J Ultrasound Med; 2022 Feb; 41(2):471-482. PubMed ID: 33890698 [TBL] [Abstract][Full Text] [Related]
37. Unilocular adnexal cysts with papillary projections but no other solid components: is there a diagnostic method that can classify them reliably as benign or malignant before surgery? Valentin L; Ameye L; Savelli L; Fruscio R; Leone FP; Czekierdowski A; Lissoni AA; Fischerova D; Guerriero S; Van Holsbeke C; Van Huffel S; Timmerman D Ultrasound Obstet Gynecol; 2013 May; 41(5):570-81. PubMed ID: 22915541 [TBL] [Abstract][Full Text] [Related]
38. Ultrasound experience substantially impacts on diagnostic performance and confidence when adnexal masses are classified using pattern recognition. Van Holsbeke C; Daemen A; Yazbek J; Holland TK; Bourne T; Mesens T; Lannoo L; Boes AS; Joos A; Van De Vijver A; Roggen N; de Moor B; de Jonge E; Testa AC; Valentin L; Jurkovic D; Timmerman D Gynecol Obstet Invest; 2010; 69(3):160-8. PubMed ID: 20016188 [TBL] [Abstract][Full Text] [Related]
39. Diagnostic performance of IOTA SR and O-RADS combined with CA125, HE4, and risk of malignancy algorithm to distinguish benign and malignant adnexal masses. Yang Y; Ju H; Huang Y Eur J Radiol; 2023 Aug; 165():110926. PubMed ID: 37418798 [TBL] [Abstract][Full Text] [Related]
40. Prospective external validation of the 'ovarian crescent sign' as a single ultrasound parameter to distinguish between benign and malignant adnexal pathology. Van Holsbeke C; Van Belle V; Leone FP; Guerriero S; Paladini D; Melis GB; Greggi S; Fischerova D; De Jonge E; Neven P; Bourne T; Valentin L; Van Huffel S; Timmerman D Ultrasound Obstet Gynecol; 2010 Jul; 36(1):81-7. PubMed ID: 20217895 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]